explore -WSS

explore

author：entertainment 2025-08-11 07:58:45 - browse：83214

Illustration of a road with a chasm in the middle, indicating the end of a deal or a problem with a deal — Adobe

A deal is never really done until it’s done.

On Tuesday, two different proposed insurance plan acquisitions on different sides of the country called it quits — one of them for the second time.

California-based Medicare Advantage insurer SCAN Group has been trying to buy CareOregon, an insurer offering coverage to half a million people in Oregon’s state health plan, since January 2023. National insurer Elevance has also been trying to buy Blue Cross and Blue Shield of Louisiana since last January. The on-again, off-again purchase was paused in September 2023 because of state regulators’ concerns, but was resubmitted with a slightly different plan in December.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Why you shouldn’t ask, “What country has the best health care?”

hotspot

WSS

FTC sues over Novant Health acquisition of two N.C. hospitals

Merck CEO won’t testify in Senate, citing no expertise in drug prices

How digital therapeutics firms are pivoting after Pear's bankruptcy

EU regulator recommends expanding Mounjaro approval to obesity

Readout Newsletter: Vertex, Pfizer, Kura, and other biotech news

Humana’s losses in Medicare Advantage tank its stock

focus

explore

focus

Medical records are filled with copy

Syphilis numbers in the United States reach record heights

Wildfire smoke exposes gaps in outdoor worker protections

Merck, Johnson & Johnson CEOs will testify on high drug prices

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Dewpoint Therapeutics lays off staff after losing partnerships

Dobbs anniversary: the lost opportunity of abortion as health care

Francis Collins on trust in science and how Covid communications failed

Trump demands the U.S. pay no more for drugs than other countries … again

eGenesis tests gene

focus

Test for long Covid? Researchers find new clue in blood samples

Research misconduct: Proposed new rules face resistance

New clues to why women have higher risk of autoimmune disorders

FTC sues over Novant Health acquisition of two N.C. hospitals

Dewpoint Therapeutics lays off staff after losing partnerships

10 reasons why health care startups fail

Wikipedia

hotspot

knowledge

hotspot